Lappuse 1 no 20 rezultātiem
DETAILED DISCLOSURE
This invention pertains to esters and amides of 2,4,6-trialkyl-3-hydroxyphenylalkanoic acids and to organic materials normally subject to oxidative, thermal and UV light deterioration stabilized with said ester and amide compounds. More specifically, the compounds of this
The invention relates to new anthranilic acid amide derivatives, processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof--alone or in combination with one or more other pharmaceutically active compounds--for the
The invention relates to new anthranilic acid amide derivatives, processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof--alone or in combination with one or more other pharmaceutically active compounds--for the
TECHNICAL FIELD
The present invention relates to certain heteroaryl amide derivatives, pharmaceutical compositions containing them, and methods of using them, including methods for preventing, reversing, slowing, or inhibiting protein aggregation, and methods of treating diseases that are associated
TECHNICAL FIELD
The present invention relates to certain heteroaryl amide derivatives, pharmaceutical compositions containing them, and methods of using them, including methods for preventing, reversing, slowing, or inhibiting protein aggregation, and methods of treating diseases that are associated
The invention relates to new anthranilic acid amide derivatives, processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof--alone or in combination with one or more other pharmaceutically active compounds--for the
BACKGROUND OF THE INVENTION
This invention relates to the novel use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents.
Neuronal death or degeneration occurs continually in mature mammals, including man. It can be accelerated for a variety of reasons including, but not limited
BACKGROUND OF THE INVENTION
This invention relates to novel use of 5phenyl-2-furan esters, amides and ketones as neuroprotective agents.
Neuronal death or degeneration occurs continually in mature mammals, including man. It can be accelerated for a variety of reasons including, but not limited to:
1. FIELD OF THE INVENTION
This invention relates to novel sulfhydryl group-containing amides and disulfide group-containing bis-amides useful for treating or preventing abnormal skin conditions or diseases, and/or improving the texture or appearance of the skin, to pharmaceutical or cosmetic
FIELD OF THE INVENTION
This invention relates to novel sulfhydryl group-containing amides and disulfide group-containing his-amides useful for treating or preventing abnormal skin conditions or diseases, and/or improving the texture or appearance of the skin, to pharmaceutical or cosmetic
The invention relates to new benzamide derivatives, processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof--alone or in combination with one or more other pharmaceutically active compounds--for the treatment
The present invention relates to a vasopressin fragment peptide derivative having nootropic activity and, therefore, of value as a drug.
It is known for years that vasopressin has nootropic activity [Int. J. Neuropharmacol. 4, 157-167(1965)]. Recently, it has been reported that certain peptides
FIELD OF THE INVENTION
This invention provides compounds and methods of use thereof for reducing the incidence, reducing the severity or pathogenesis, or treating a disease or disorder of the eye in a subject, including, inter alia, retinal detachment, macular degeneration, glaucoma or retinopathy,
This invention relates to a new base for ophthalmological medicinal 12) preparations and a new ophthalmological medicinal film. preparations. opthalomology
The described biologically soluble polymeric base for ophthalmological medicinal preparations, biologically compatible with eye tissues, is
This invention relates to a new base for ophthalmological medicinal preparations and a new ophthalmological medicinal film.
The described biologically soluble polymeric base for ophthalmological medicinal preparations, biologically compatible with eye tissues, is intended for therapeutic treatment